Some people with rectal cancer may be able to avoid chemotherapy, radiation and major surgery after a new US approval for the immunotherapy drug dostarlimab. The decision applies only to a specific ...

The approval only covers a narrow group of rectal cancer patients, but for them it may rewrite what treatment looks like.

A newly approved immunotherapy was effective for some forms of rectal cancer without the need for additional treatments.

Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug ...

A new treatment for locally advanced rectal cancer shows favorable results in that surgery can sometimes be avoided completely. It also reduces the risk of recurrence. The method has been confirmed as ...

A new treatment for locally advanced rectal cancer shows favourable results in that surgery can sometimes be avoided completely. It also reduces the risk of recurrence. The method has been confirmed ...

A new treatment for earlier-stage rectal cancer could transform how patients are treated for the disease, according to a landmark clinical trial. The clinical trial was coordinated by the Cancer ...

Having an ostomy is a dreaded prospect for many patients with rectal cancer. To defer, and potentially avoid, this life-altering surgery, the watch-and-wait approach has become increasingly common ...

Ryan Moore, MD, discusses the choice between surgery and total neoadjuvant therapy (TNT) for rectal cancer and when watch-and ...